Mini review: surveillance of Lyme borreliosis in Southeast Asia and method of diagnosis

Eur Rev Med Pharmacol Sci 2023; 27 (10): 4378-4385

DOI: 10.26355/eurrev_202305_32443

K.J. Teh, H.Y. Tang, L.S. Lim, H.S. Pung, S.Y. Gan, N.S. Lai

Medical Innovation Ventures Sdn, Bhd (Mediven), Bayan Lepas, Malaysia. admin@mediven.com.co

Lyme borreliosis is caused by the Gram-negative spirochetes Borrelia spp., particularly Borrelia burgdorferi sensu lato complex. The disease is transmitted through the bite of the infected black-legged Ixodes tick. Lyme borreliosis extensively occurs in the Northern Hemisphere, mainly in the United States. Lyme borreliosis cases are also detected in Asian countries including Korea, Nepal, China, Taiwan, and Japan. However, there is an inadequate understanding of Lyme borreliosis in the Southeast Asian region. Hence, this review aims to provide a brief update on the prevalence of Lyme borreliosis infection in Southeast Asia based on the latest literature on this issue. Lyme borreliosis has been discovered in human serum in Indonesia, Malaysia, and Singapore. The human serum samples were mainly examined with ELISA test using Borrelia spp. IgG and IgM antigens. Borrelia spp. also has been detected in ticks found on host animals such as Sundamys muelleri and Python in Malaysia, Thailand, and Laos. Polymerase chain reaction (PCR) is used to detect the presence of Borrelia DNAs in the samples. The published studies have demonstrated that Borrelia spp. exists in Southeast Asia and although the incidence is relatively low, it is believed that Lyme disease cases are under-reported.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

K.J. Teh, H.Y. Tang, L.S. Lim, H.S. Pung, S.Y. Gan, N.S. Lai
Mini review: surveillance of Lyme borreliosis in Southeast Asia and method of diagnosis

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 10
Pages: 4378-4385
DOI: 10.26355/eurrev_202305_32443

留言 (0)

沒有登入
gif